Aims/hypothesis Bone marrow (BM)-derived endothelial progenitor cells (EPC) promote
tissue healing and angiogenesis, whereas altered EPC biology may favour diabetic …

Diabetic patients suffer from impaired wound healing, characterized by only modest
angiogenesis and cell proliferation. Stem cells may stimulate healing, but little is known …

Bone marrow (BM)-derived endothelial progenitor cells (EPC) contribute to vascular
maintenance by participating in angiogenesis, re-endothelialization, and remodeling …

Bone marrow stem cells participate in tissue repair processes and may have roles in skin
wound repair. Diabetes is characterized by delayed and poor wound healing, and type 1 …

Impaired wound healing leading to skin ulceration is a serious complication of diabetes and
may be caused by defective angiogenesis. Endothelial progenitor cells (EPCs) can augment …

Background Circulating Endothelial Progenitor Cell (EPC) levels are reduced in diabetes
mellitus. This may be a consequence of impaired mobilization of EPC from the bone marrow …

Summary 1 Circulating bone marrow (BM)‐derived endothelial progenitor cells (EPCs) play
an important role in neovascularization. In the present study, we investigated the …

Type 1 diabetes is associated with reduced vascular repair, as indicated by impaired wound
healing and reduced collateral formation in ischemia. Recently, endothelial progenitor cells …

OBJECTIVE: To assess the contribution of bone marrow (BM)-derived endothelial progenitor
cells (EPCs) to the neovascularisation of cutaneous incisional wounds. METHODS: Lethally …

Traditionally, the development of diabetic complications has been attributed to the
biochemical pathways driving hyperglycaemic cell damage, while reparatory mechanisms …